Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

about

Cumulative evidence for MS as a neural network disconnection syndrome consistent with cognitive impairment mechanisms and the confounding role of fatigue and depression-outlook from the Fourth Nordic MS symposium.

P2860

Q38942618-2EF4088A-55EE-4B4A-86A2-18E4517544C1

P2860

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

Item

http://www.wikidata.org/entity/Q38855448

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

@en

type

Item

label

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

@en

prefLabel

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

@en

P1476

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

@en

P2093

P S Rommer

http://www.w3.org/2001/XMLSchema#string

S Skierlo

http://www.w3.org/2001/XMLSchema#string

U K Zettl

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the clinical course of multiple sclerosis: Results of an international survey

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Multiple sclerosis

[Epidemiology of multiple sclerosis in Germany: regional differences and drug prescription in the claims data of the statutory health insurance].

Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients.

Employment among patients with multiple sclerosis-a population study.

Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.

Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS

Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings.

Prevalence of stress urinary incontinence in women with multiple sclerosis.

P304

394-399

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ANE.12612

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27283842

http://www.w3.org/2001/XMLSchema#string

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

about

P2860

P2860

Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698